Berlin-Berlin state hospital groups Charite and Vivantes have stopped vaccination of women under the age of 55 with AstraZeneca’s COVID-19 vaccine, a hospital spokeswoman said Tuesday.
This move follows reports of rare but severe blood clots, bleeding, and possibly post-vaccination death, mainly in young women.
“From a Charite point of view, this step is necessary because, in the meantime, German women became more aware of cerebral venous thrombosis,” a spokeswoman said in an email.
Charite said the behavior was prophylactic while they were waiting for the final evaluation. No complications have occurred in the hospital since the AstraZeneca vaccination.
A spokeswoman for the Vivantes Clinic also said the move to suspend injections for young women was a precautionary measure.
Approximately 19,000 people work at Charite Hospital and 17,000 at Vivantes, which operates clinics and long-term care facilities.
Tages Spiegel, who first reported the decision, said that about two-thirds of Charite’s staff had been vaccinated so far, and 70% of their workers had been vaccinated with a single dose of AstraZeneca vaccine. I did.
Many European countries have temporarily stopped using vaccines from a British-Swedish company while investigating a blood clot case earlier this month.
Since then, almost all countries have resumed use of the AstraZeneca vaccine. However, France went bankrupt under the guidance of European health regulators and said it should only be given to people over the age of 55 on March 19. France said the decision was based on evidence that coagulation affected young people.
Canadian health officials said Monday that they would stop offering AstraZeneca shots to people under the age of 55 and need a new analysis of the benefits and risks of shots based on age and gender.
Maria Sheehan and Caroline Copley